VR Adviser, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
VA VR Adviser, LLC | Institutional Filer | ▲ 32.33% | $2.68B | 33 |
Current Portfolio Holdings
Showing all 33 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | APGE | Apogee Therapeutics, Inc. | Healthcare | 8.5M | $714.9M | 26.68% |
| 2 | ERAS | Erasca, Inc. | Healthcare | 16.4M | $265.1M | 9.89% |
| 3 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 4.1M | $203.5M | 7.60% |
| 4 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 3.7M | $185.9M | 6.94% |
| 5 | KALV | KalVista Pharmaceuticals, Inc. | Healthcare | 6.5M | $130.3M | 4.86% |
| 6 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 1.2M | $99.0M | 3.70% |
| 7 | GLTO | Galecto, Inc. | Healthcare | 3.6M | $93.3M | 3.48% |
| 8 | OCUL | Ocular Therapeutix, Inc. | Healthcare | 10.3M | $87.6M | 3.27% |
| 9 | COGT | Cogent Biosciences, Inc. | Healthcare | 2.0M | $77.0M | 2.87% |
| 10 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 3.9M | $75.9M | 2.83% |
| 11 | SVRA | Savara Inc. | Healthcare | 13.7M | $75.0M | 2.80% |
| 12 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 1.7M | $67.7M | 2.53% |
| 13 | ORIC | ORIC Pharmaceuticals, Inc. | Healthcare | 4.3M | $54.7M | 2.04% |
| 14 | VOR | Vor Biopharma Inc. | Healthcare | 3.0M | $54.3M | 2.03% |
| 15 | MAZE | Maze Therapeutics, Inc. | Healthcare | 1.6M | $47.8M | 1.78% |
Showing 1 to 15 of 33 holdings